4
MARKET OVERVIEW
Presents a concise view of industry direction, strategic priorities, and key indicators influencing market momentum.
4.2
UNMET NEEDS AND WHITE SPACES
4.3
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.4
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
Captures industry movement, adoption patterns, and strategic signals across key end-use segments and regions.
5.1
PORTER’S FIVE FORCES ANALYSIS
5.1.1
THREAT OF NEW ENTRANTS
5.1.2
BARGAINING POWER OF SUPPLIERS
5.1.3
BARGAINING POWER OF BUYERS
5.1.4
THREAT OF SUBSTITUTES
5.1.5
INTENSITY OF COMPETITIVE RIVALRY
5.2
MACROECONOMIC INDICATORS
5.2.1
GDP TRENDS AND FORECAST
5.2.2
TRENDS IN US CONTRAST MEDIA INDUSTRY
5.4
SUPPLY CHAIN ANALYSIS
5.6.1
AVERAGE SELLING PRICE TREND, BY KEY PLAYER,2023–2025
5.6.2
AVERAGE SELLING PRICE TREND, BY PRODUCT TYPE, 2023–2025
5.8
KEY CONFERENCES AND EVENTS, 2026–2027
5.9
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.10
INVESTMENT AND FUNDING SCENARIO
5.12
IMPACT OF 2025 US TARIFF
5.12.2
PRICE IMPACT ANALYSIS
5.12.4
IMPACT ON END-USE INDUSTRIES
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.2
COMPLEMENTARY TECHNOLOGIES
6.3
TECHNOLOGY/PRODUCT ROADMAP
6.5.1
TOP USE CASES AND MARKET POTENTIAL
6.5.3
CASE STUDIES OF AI IMPLEMENTATION
6.5.4
INTERCONNECTED ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.5.5
CLIENTS’ READINESS TO ADOPT AI
6.6
SUCCESS STORIES AND REAL-WORLD APPLICATIONS
7.1
REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
8
CUSTOMER LANDSCAPE AND BUYER BEHAVIOR
8.1
DECISION-MAKING PROCESS
8.2
KEY STAKEHOLDERS AND BUYING CRITERIA
8.3
ADOPTION BARRIERS AND INTERNAL CHALLENGES
8.4
UNMET NEEDS FROM END-USE INDUSTRIES
9
US CONTRAST MEDIA MARKET DATA, BY TYPE (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION)
9.1
IODINATED CONTRAST MEDIA
9.2
GADOLINIUM-BASED CONTRAST MEDIA
9.3
MICROBUBBLE CONTRAST MEDIA
9.4
BARIUM-BASED CONTRAST MEDIA
10
US CONTRAST MEDIA MARKET DATA, BY FORM (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION)
11
US CONTRAST MEDIA MARKET DATA, BY MODALITY (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION)
12
US CONTRAST MEDIA MARKET DATA, BY ROUTE OF ADMINISTRATION (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION)
12.1.2
INTRA-ARTERIAL ROUTE
13
US CONTRAST MEDIA MARKET DATA, BY INDICATION (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION)
13.1
CARDIOVASCULAR DISEASES
13.3
GASTROINTESTINAL DISORDERS
13.4
MUSCULOSKELETAL DISORDERS
13.5
NEUROLOGICAL DISORDERS
13.6
NEPHROLOGICAL DISORDERS
14
US CONTRAST MEDIA MARKET DATA, BY APPLICATION (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION)
14.2
INTERVENTIONAL RADIOLOGY
14.3
INTERVENTIONAL CARDIOLOGY
15
US CONTRAST MEDIA MARKET DATA, BY END USER (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION)
15.1
HOSPITALS, CLINICS, & AMBULATORY SURGERY CENTERS
15.2
DIAGNOSTIC IMAGING CENTERS
16.2
KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022–2025
16.3
REVENUE ANALYSIS, 2021–2025
16.4
MARKET SHARE ANALYSIS,
16.5
COMPANY EVALUATION MATRIX: KEY PLAYERS,
16.5.5
COMPANY FOOTPRINT: KEY PLAYERS,
16.5.5.1
COMPANY FOOTPRINT
16.5.5.4
MODALITY FOOTPRINT
16.5.5.5
ROUTE OF ADMINISTRATION FOOTPRINT
16.5.5.6
INDICATION FOOTPRINT
16.5.5.7
APPLICATION FOOTPRINT
16.5.5.8
END USER FOOTPRINT
16.6
COMPANY EVALUATION MATRIX: START-UPS/SMES,
16.6.1
PROGRESSIVE COMPANIES
16.6.2
RESPONSIVE COMPANIES
16.6.5
COMPETITIVE BENCHMARKING: START-UPS/SMES,
16.6.5.1
LIST OF START-UPS/SMES
16.6.5.2
COMPETITIVE BENCHMARKING OF START-UPS/SMES
16.7
C0MPETITIVE SCENARIO
16.7.1
PRODUCT LAUNCHES/APPROVALS
16.7.3
OTHER DEVELOPMENTS
16.8
BRAND/PRODUCT COMPARISON PRODUCT COMPARISON
16.9
COMPANY VALUATION AND FINANCIAL METRICS
17.1.2
TRIVITRON HEALTHCARE
17.1.3
BRACCO IMAGING S.P.A.
17.1.6
IMAX DIAGNOSTIC IMAGING
17.1
9 LANTHEUS MEDICAL IMAGING
17.1.10
AMNEAL PHARMACEUTICALS
17.1.11
HIKMA PHARMACEUTICALS
17.1
12 MALLINCCKRODT PHARMACEUTICALS
17.1.14
SAGENT PHARMACEUTICALS
17.2.1
NANO THERAPEUTICS PVT
17.2.2
REVEAL PHARMACEUTICALS
17.2.6
ADVANCED MICROBUBBLES INC.
17.2.7
REGE IMAGING & CINE FILMS PRIVATE LIMITED.
17.2.9
UNISPIRE BIOPHARMA PRIVATE LIMITED
18.1.1
SECONDARY RESEARCH
18.1.2.2
KEY INDUSTRY INSIGHTS
18.1.2.3
BREAKDOWN OF PRIMARIES
18.2
MARKET SIZE ESTIMATION
18.2.1
REVENUE-MAPPING BASED MARKET ESTIMATION
18.2.2
END-USER BASED MARKET ESTIMATION
18.3
MARKET FORECASTING APPROACH
18.4
MARKET BREAKDOWN AND DATA TRIANGULATION
18.5
RESEARCH ASSUMPTIONS
18.6
RESEARCH LIMITATIONS
18.6.1
SCOPE-RELATED LIMITATIONS
18.6.2
METHODOLOGY-RELATED LIMITATIONS
19.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
19.3
CUSTOMIZATION OPTIONS
Growth opportunities and latent adjacency in US Contrast Media Market